Page 511 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

CHAPTER 23 Cancer of the Gastrointestinal Tract 489

536. Holt PE, Durdey P: Transanal endoscopic treatment of benign 558. Nielsen SW, Aftosmis J: Canine perianal gland tumors, J Am Vet
canine rectal tumours: preliminary results in six cases (1992 to Med Assoc 144:127–135, 1964.
1996), J Small Anim Pract 40:423–427, 1999. 559. Maita K, Ishida K: Structure and development of the perianal gland
VetBooks.ir 537. Coleman KA, Berent AC, Weisse CW: Endoscopic mucosal resec- 560. Vinayak A, Frank CB, Gardiner DW, et al.: Malignant anal sac
of the dog, Japan J Vet Sci 37:349–356, 1975.
tion and snare polypectomy for treatment of a colorectal polypoid
adenoma in a dog, J Am Vet Med Assoc 244:1435–1440, 2014.
538. Nucci DJ, Liptak JM, Selmic LE, et al.: Complications and melanoma in dogs: eleven cases (2000 to 2015), J Small Anim Pract
58:231–237, 2017.
outcomes following rectal pull-through surgery in dogs with 561. Esplin DG, Wilson SR, Hullinger GA: Squamous cell carcinoma of
rectal masses: 74 cases (2000-2013), J Am Vet Med Assoc 245: the anal sac in five dogs, Vet Pathol 40:332–334, 2003.
684–695, 2014. 562. Mellett S, Verganti S, Murphy S, et al.: Squamous cell carci-
539. Morello E, Martano M, Squassino C, et al.: Transanal pull-through noma of the anal sacs in three dogs, J Small Anim Pract 56:
rectal amputation for treatment of colorectal carcinoma in 11 dogs, 223–225, 2015.
Vet Surg 37:420–426, 2008. 563. Giuliano A, Dobson J, Mason S: Complete resolution of a recur-
540. Hardie EM, Gilson SD: Use of colostomy to manage rectal disease rent canine anal sac squamous cell carcinoma with palliative radio-
in dogs, Vet Surg 26:270–274, 1997. therapy and carboplatin chemotherapy, Vet Sci 43:E45, 2017.
541. Swiderski J, Withrow S: A novel surgical stapling technique for rec- 564. Emms SG: Anal sac tumours of the dog and their response
tal mass removal: a retrospective analysis, J Am Anim Hosp Assoc to cytoreductive surgery and chemotherapy, Aust Vet J 83:
45:67–71, 2009. 340–343, 2005.
542. Kupanoff PA, Popovitch CA, Goldschmidt MH: Colorectal plas- 565. Shoieb AM, Hanshaw DM: Anal sac gland carcinoma in
macytomas: a retrospective study of nine dogs, J Am Anim Hosp 64 cats in the United Kingdom (1995-2007), Vet Pathol 46:
Assoc 42:37–43, 2006. 677–683, 2009.
543. Arteaga TA, McKnight J, Bergman PJ: A review of 18 cases of feline 566. Amsellem PM, Cavanaugh RP, Chou PY, et al.: Apocrine gland
colonic adenocarcinoma treated with subtotal colectomies and anal sac adenocarcinoma in cats: 30 cases (1994-2015), J Am Vet
adjuvant carboplatin, J Am Anim Hosp Assoc 48:399–404, 2012. Med Assoc, in press, 2018.
544. Moore AS, Kirk C, Cardona A: Intracavitary cisplatin chemother- 567. Elliott JW, Blackwood L: Treatment and outcome of four cats with
apy experience with six dogs, J Vet Intern Med 5:227–231, 1991. apocrine gland carcinoma of the anal sac and review of the litera-
545. Elliott JW, Swinbourne F, Parry A, et al.: Successful treatment of a ture, J Feline Med Surg 13:712–717, 2011.
metastatic, gastrointestinal stromal tumour in a dog with toceranib 568. Berrocal A, Vos JH, van den Ingh TS, et al.: Canine perineal
phosphate (Palladia), J Small Anim Pract 58:416–418, 2017. tumours, J Vet Med Ser A 36:739–749, 1989.
546. Kobayashi M, Kuroki S, Ito K, et al.: Imatinib-associated tumour 569. Wilson GP, Hayes HM: Castration for treatment of perianal gland
response in a dog with a non-resectable gastrointestinal stro- neoplasms in the dog, J Am Vet Med Assoc 174:1301–1303, 1979.
mal tumour harbouring a c-kit exon 11 deletion mutation, Vet J 570. Chaisiri N, Pierrpoint CG: Steroid-receptor interaction in a canine
198:271–274, 2013. anal adenoma, J Small Anim Pract 20:405–416, 1979.
547. Kobayashi M, Sugisaki O, Ishii N, et al.: Canine intestinal mast cell 571. Dow SW, Olson PN, Rosychuk RA, et al.: Perianal adeno-
tumor with c-kit exon 8 mutation responsive to imatinib therapy, mas and hypertestosteronemia in a spayed bitch with pituitary-
Vet J 193:264–267, 2012. dependent hyperadrenocorticism, J Am Vet Med Assoc 192:
548. Coit DG: Cancer of the small intestine. In DeVita VT, Hellman S, 1439–1441, 1988.
Rosenberg SA, editors: Cancer: principles and practice of oncology, ed 6, 572. Hill KE, Scott-Montrieff CR, Koshko MA, et al.: Secretion of sex
Lippincott Williams & Wilkins, 2001. hormones in dogs with adrenal dysfunction, J Am Vet Med Assoc
549. Skibber JM, Minsky BD, Hoff PM: Cancer of the colon. In DeVita 226:556–561, 2005.
VT, Hellman S, Rosenberg SA, editors: Cancer: principles and prac- 573. Goldschmidt MH, Dunstan RW, Stannard AA, et al.: Histological
tice of oncology, ed 6, Philadelphia, 2001, Lippincott Williams & classification of epithelial and melanocytic tumors of the skin of
Wilkins. domestic animals. In WHO international histological classification
550. Youmans L, Taylor C, Shin E, et al.: Frequent alteration of the of tumors of domestic animals. 2nd Series, Vol. 3. Washington DC,
tumor suppressor gene APC in sporadic canine colorectal tumors, 1998, Armed Forces Institute of Pathology, pp 38–40.
PLoS One 7:e50813, 2012. 574. Pereira RS, Schweigert A, Dias de Melo GD, et al.: Ki-67 label-
551. Squire JA, Whitmore GF, Phillips RA: Genetic basis of cancer. In ing in canine perianal glands neoplasms: a novel approach for
Tannock IF, Hill RP, editors: The basic science of oncology, ed 3, immunohistological diagnostic and prognostic, BMC Vet Res 9:
New York, 1998, McGraw-Hill. 83, 2013.
552. Dailey DD, Ehrhart EJ, Duval DL, et al.: DOG1 is a sensitive and 575. Sobczyńska-Rak A, Brodzki A: VEGF and 17-β-estradiol levels
specific immunohistochemical marker for diagnosis of canine gas- after tamoxifen administration in canine hepatoid gland adenomas
trointestinal stromal tumors, J Vet Diagn Invest 27:268–277, 2015. and hepatoid gland epitheliomas, In Vivo 28:871–878, 2014.
553. Sawaki A, Yamao K: Imatinib mesylate acts in metastatic or 576. Vail DM, Withrow SJ, Schwarz PD, et al.: Perianal adenocarci-
unresectable gastrointestinal stromal tumor by targeting KIT noma in the canine male: a retrospective study of 41 cases, J Am
receptors—a review, Cancer Chemother Pharmacol 54(Suppl 1): Anim Hosp Assoc 26:329–334, 1990.
S44–49, 2004. 577. Martins AMCRPF, Vasques-Peyser A, Torres LN, et al.: Retrospec-
554. Peek Jr RM: Prevention of colorectal cancer through the use of tive-systematic study and quantitative analysis of cellular prolifera-
COX-2 selective inhibitors, Cancer Chemother Pharmacol 54(Suppl tion and apoptosis in normal, hyperplastic and neoplastic perianal
1):S50–56, 2004. glands in dogs, Vet Comp Oncol 6:71–79, 2008.
555. Oberthaler KT, Shofer FS, Bowden A: Chemoprevention using 578. Brodzki A, Lopuszyński W, Brodzki P, et al.: Diagnostic and prog-
NSAIDs in dogs: A preliminary epidemiological survey. Proceed- nostic value of cellular proliferation assessment with Ki-67 protein
ing 24th annual conference of the Veterinary Cancer Society, 3. in dogs suffering from benign and malignant perianal tumors, Folia
556. Nishida T, Doi T, Naito Y: Tyrosine kinase inhibitors in the treat- Biol 62:235–241, 2014.
ment of unresectable or metastatic gastrointestinal stromal tumors, 579. Gamblin RM, Sagartz JE, Couto CG: Overexpression of p53
Expert Opin Pharmacother 15:1979–1989, 2014. tumor suppressor protein in spontaneously arising neoplasms of
557. Meyers BM, Cosby R, Quereshy F, et al.: Adjuvant Chemotherapy dogs, Am J Vet Res 58:857–863, 1997.
for Stage II and III Colon Cancer Following Complete Resection: 580. Nakano M, Taura Y, Inoue M: Protein expression of Mdm2 and
a cancer care ontario systematic review, Clin Oncol (R Coll Radiol) p53 in hyperplastic and neoplastic lesions of the canine circumanal
29:459–465, 2017. gland, J Comp Pathol 132:27–32, 2005.